WFG Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-480
Closed -$38K 1764
2016
Q4
$38K Sell
480
-1,384
-74% -$110K 0.01% 786
2016
Q3
$149K Sell
1,864
-745
-29% -$60.1K 0.04% 435
2016
Q2
$203K Sell
2,609
-926
-26% -$66K 0.05% 334
2016
Q1
$194K Buy
3,535
+504
+17% +$27.5K 0.06% 308
2015
Q4
$187K Sell
3,031
-77
-2% -$4.86K 0.06% 304
2015
Q3
$196K Sell
3,108
-264
-8% -$18.8K 0.06% 297
2015
Q2
$246K Sell
3,372
-64
-2% -$4.62K 0.07% 287
2015
Q1
$225K Buy
3,436
+43
+1% +$2.86K 0.06% 324
2014
Q4
$221K Sell
3,393
-82
-2% -$5.28K 0.04% 396
2014
Q3
$209K Sell
3,475
-5,116
-60% -$334K 0.04% 435
2014
Q2
$595K Buy
8,591
+283
+3% +$18.3K 0.11% 216
2014
Q1
$543K Sell
8,308
-1,839
-18% -$120K 0.11% 224
2013
Q4
$629K Sell
10,147
-22
-0.2% -$1.27K 0.09% 259
2013
Q3
$545K Buy
10,169
+2,111
+26% +$109K 0.08% 267
2013
Q2
$368K Buy
+8,058
New +$349K 0.06% 320

Other funds holding STJ

WFG Advisors's STJ Position: Q1 2017 in Review

WFG Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 480 shares — an estimated $38K sold.

WFG Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $629K in Q4 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • WFG Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • WFG Advisors sold 480 St Jude Medical shares in Q1 2017, an estimated $38K.
  • WFG Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • WFG Advisors's St Jude Medical position peaked at $629K in Q4 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on WFG Advisors's 13F filing for Q1 2017, filed 10 May 2017.